The Khayelitsha programme was the first in South Africa to provide antiretroviral therapy (ART) at primary care in the public sector. It is also one of two pilot projects in the country to provide decentralized care for drug-resistant tuberculosis (DR-TB).
This report highlights the key clinical, programmatic, and policy changes that have supported universal coverage for HIV and TB care and outlines future challenges and potential models for long term ART care.
Khayelitsha Report 2008-2009
pdf — 1.76 MB